Role of the renin-angiotensin system in disorders of the urinary tract

Journal of Urology

Volumn 160, Issue 5, 1998, Pages 1812-1819

  Brock III, John W ^a   Hunley, Tracy E ^a   Adams, Mark C ^a   Kon, Valentina ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Abnormalities; Angiotensins; Kidney; Urinary tract

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; BRADYKININ; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELECTROLYTE; IMMUNOGLOBULIN A; RENIN;

BLOOD PRESSURE; FETUS DEVELOPMENT; GENE MUTATION; GENETIC ENGINEERING; GENETIC POLYMORPHISM; GENOTYPE; HOMEOSTASIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; URETER OBSTRUCTION; URETHRA VALVE; URINARY TRACT DISEASE; VESICOURETERAL REFLUX;

EID: 0344549172     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62423-6     Document Type: Review

References (85)

1. Stephens, F. D.: Megaureters. In: Congenital Anomalies of the Urinary and Genital Tracts. Edited by F. D. Stephens, E. D. Smith and J. M. Hutson. Oxford: Isis, chapt. 17, pp. 193-210, 1996.
2. Ransley, P. G. and Risdon, R. A.: Reflux and renal scarring: Brit. J. Rad., 14: 1, 1978.
3. Ransley, P. G., Risdon, R. A. and Godley, M. L.: High pressure sterile vesicoureteral reflux and renal scarring: an experimental study in the pig and minipig. Contr. Nephrol., 39: 320, 1984.
4. Bailey, R. R.: The relationship of vesico-ureteric reflux to urinary tract infection and chrome pyelonephritis - reflux nephropathy. Clin. Nephrol., 1: 132, 1973.
5. Rolleston, G. L., Maling, T. M. and Hudson, C. J.: Intrarenal reflux and the scarred kidney. Arch. Dis. Child., 49: 531, 1974.
6. Smellie, J. M., Edwards, D., Normand, I. C. and Prescod, N.: Effect of vesicoureteric reflux on renal growth in children with urinary tract infection. Arch. Dis. Child., 56: 593, 1981.
7. Koff, S. A. and Murtagh, D. S.: The uninhibited bladder in children: effect of treatment on recurrence of urinary infection and on vesicoureteral reflux resolution. J. Urol., 130: 1138, 1983.
8. Brewer, S. B., Colodny, A. H. and Retik, A. B.: The management of vesicoureteral reflux in children with myelodysplasia. J. Urol., 128: 102, 1982.
9. Jörgensen, T. M. and Stödkilde-Jörgenson, H.: Dynamics of the upper urinary tract during induced vesico-ureteric reflux in pigs. II. Scand. J. Urol. Nephrol., 19: 173, 1985.
10. Ransley, P. G. and Risdon, R. A.: Renal papillary morphology in infants and young children. Urol. Res., 3: 111, 1975.
11. Djurhuus, J. C.: Kidney function in bladder substitution. Scand. J. Urol. Nephrol., suppl., (S)142:54, 1992.
12. Najmaldin, A., Burge, D. M. and Atwell, J. D.: Reflux nephropathy secondary to intrauterine vesicoureteral reflux. J. Ped. Surg., 25: 387, 1990.
13. Stephens, F. D.: Normal embryology of the upper urinary tract and kidney. In: Congenital Anomalies of the Urinary and Genital Tracts. Edited by F. D. Stephens, E. D. Smith and J. M. Hutson. Oxford: Iris, chapt. 27, p. 283, 1996.
14. Morita, T., Ishizuka, G. and Tsuchida, S.: Initiation and propagation of stimulus from the renal pelvic pacemaker in pig kidneys. Invest. Urol., 19: 157, 1981.
15. Williams, D. I. and Kenawi, M. M.: The prognosis of pelvaureteric obstruction in childhood: a review of 190 cases. Eur. Urol., 2: 57, 1976.
16. McFarlane, J. R. and Young, D. G.: Pelvoureteric junction obstruction in children. Zeitschr. Kinderchir., 33: 64, 1981.
17. Parker, R. M., Rudd, T. G., Wonderly, R. K. and Ansell, J. S.: UPJ obstruction in infants and children: functional evaluation of the obstructed kidney preoperatively and postoperatively. J. Urol., 126: 509, 1981.
18. McCrory, W. W.: Regulation of renal functional development. Urol. Clin. N. Amer., 7: 243, 1980.
19. McCrory, W. W., Shibuya, M., Leumann, E. and Karp, R.: Studies of renal function in children with chronic hydronephrosis. Ped. Clin. N. Amer., 18: 445, 1971.
20. King, L. R., Coughlin, P. W. F., Bloch, E. C., Bowie, J. D., Ansong, K. and Hanna, M. K.: The case for immediate pyeloplasty in the neonate with ureteropelvic junction obstruction. J. Urol., 132: 725, 1984.
21. Pope, J. C., IV, Showalter, P. R., Milam, D. F. and Brock, J. W., III: Intrapelvic pressure monitoring in the partially obstructed porcine kidney. Urology, 44: 565, 1994.
22. Stephens, F. D.: Congenital intrinsic lesions of the posterior urethra. In: Congenital Malformations of the Urinary Tract. New York: Praeger Publishers, chapt. 5, p. 95-125, 1983.
23. Livne, P. M., Delaune, J. and Gonzales, E. T., Jr.: Genetic etiology of posterior urethral valves. J. Urol., 130: 781, 1983.
24. Crankston, S. and Ahmed, S.: Prenatal diagnosis of posterior urethral valves in siblings. Aust. New Zeal. J. Surg., 63: 143, 1993.
25. Churchill, B. M., Krueger, R. P., Fleisher, M. H. and Hardy, B. E.: Complications of posterior urethral valve surgery and their prevention. Urol. Clin. N. Amer., 10: 519, 1983.
26. Williams, D. I., Whitaker, R. H., Barratt, T. M. and Keeton, J. E.: Urethral valves. Brit. J. Urol., 45: 200, 1973.
27. Johnston, J. H. and Kulatilake, A. E.: The sequelae of posterior urethral valves. Brit. J. Urol., 43: 743, 1971.
28. Krueger, R. P., Hardy, B. E. and Churchill, B. M.: Growth in boys with posterior urethral valves. Primary valve resection vs. upper tract diversion. Urol. Clin. N. Amer., 7: 265, 1980.
29. Hutton, K. A. R., Thomas, D. F. M., Arthur, R. J., Irving, H. C. and Smith, S. E. W.: Prenatally detected posterior urethral valves: is gestational age at detection a predictor of outcome? J. Urol., 152: 698, 1994.
30. Scott, J. E.: Management of congenital posterior urethral valves. Brit. J. Urol., 57: 71, 1985.
31. Warshaw, B. L., Hymes, L. C., Trulock, T. S. and Woodard, J. R.: Prognostic features in infants with obstructive uropathy due to posterior urethral valves. J. Urol., 133: 240, 1985.
32. Duckett, J. W.: Management of posterior urethral valves. AUA Update Series, vol. 2, lesson 38, 1983.
33. Rittenberg, M. H., Hulbert, W. C., Snyder, H. M., III and Duckett, J. W.: Protective factors in posterior urethral valves. J. Urol., 140: 993, 1988.
34. Hoover, D. L. and Duckett, J. W.: Posterior urethral valves, unilateral reflux, and renal dysplasia: a syndrome. J. Urol., 128: 994, 1982.
35. Henneberry, M. O. and Stephens, F. D.: Renal hypoplasia and dysplasia in infants with posterior urethral valves. J. Urol., 123: 912, 1980.
36. Dinneen, M. D., Dhillon, H. K., Ward, H. C., Duffy, P. G. and Ransley, P. G.: Antenatal diagnosis of posterior urethral valves. Brit. J. Urol., 72: 364, 1993.
37. Jee, L. D., Rickwood, A. M. and Turnock, R. R.: Posterior urethral valves. Does prenatal diagnosis influence prognosis? Brit. J. Urol., 72: 830, 1993.
38. Freedman, A. L., Bukowski, T. P., Smith, C. A., Evans, M. I., Johnson, M. P. and Gonzalez, R.: Fetal therapy for obstructive uropathy: specific outcomes diagnosis. J. Urol., 156: 720, 1996.
39. Smith, G. H. H., Canning, D. A., Schulman, S. L., Snyder, H. M., III and Duckett, J. W.: The long-term outcome of posterior urethral valves treated with primary ablation and observation. J. Urol., 155: 1730, 1996.
40. Close, C. E., Carr, M. C., Burns, M. W. and Mitchell, M. E.: Lower urinary tract changes after primary valves ablation in neonates and infants: is early diversion warranted? J. Urol., 157: 984, 1997.
41. Shotan, A., Widerhorn, J., Hurst, A. and Elkayam, U.: Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Amer. J. Med., 96: 451, 1994.
42. Kreft-Jais, C., Plouin, P. F., Tchobroutsky, C. and Boutroy, M. J.: Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril. Brit. J. Obst. Gynaec., 95: 420, 1988.
43. Sedman, A. B., Kershaw, D. B. and Bunchman, T. E.: Recognition and management of angiotensin converting enzyme inhibitor fetopathy. Ped. Nephrol., 9: 382, 1995.
44. Pryde, P. G., Sedman, A. B., Nugent, C. E. and Barr, M., Jr.: Angiotensin-converting enzyme inhibitor fetopathy. J. Amer. Soc. Nephrol., 3: 1575, 1993.
45. Barr, M., Jr. and Cohen, M. M., Jr.: ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology, 44: 485, 1991.
46. Tanimota, K., Sugiyama, F., Gota, Y., Ishida, J., Takimoto, E., Yagami, K., Fukamizu, A. and Murakami, K.: Angiotensinogen-deficient mice with hypotension. J. Biol. Chem., 269: 31334, 1994.
47. Niimura, F., Okubo, S., Fogo, A. and Ichikawa, I.: Temporal and spatial expression pattern of the angiotensinogen gene in mice and rats. Amer. J. Physiol., 272: R142, 1997.
48. Niimura, F., Labosky, P. A., Kakuchi, J., Okubo, S., Yoshida, H., Oikawa, T., Ichiki, T., Naftilan, A. J., Fogo, A., Inagami, T., Hogan, B. L. M. and Ichikawa, I.: Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J. Clin. Invest., 96: 2947, 1995.
49. Esther, C. R., Jr., Howard, T. E., Marino, E. M., Coddard, J. M., Capecchi, M. R. and Bernstein, K. E.: Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab. Invest., 74: 953, 1996.
50. Carpenter, C., Honkanen, A. A., Mashimo, H., Goss, K. A., Huang, P., Fishman, M. C., Asad, M., Dorso, C. R. and Cheung, H.: Renal abnormalities in mutant mice. Nature, 380: 292, 1996.
51. Krege, J. H., John, S. W., Langenbach, L. L., Hodgin, J. B., Hagaman, J. R., Bachman, E. S., Jennette, J. C., O'Brien, D. A. and Smithies, O.: Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature, 375: 146, 1995.
52. Kim, H.-S., Krege, J. H., Kluckman, K. D., Hagaman, J. R., Hodgin, J. B., Best, C. F., Jennette, J. C., Coffman, T. M., Maeda, N. and Smithies, O.: Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci., 92: 2735, 1995.
53. Alfie, M. E., Shesely, E. G., Alim, S. and Caretero, O. A.: Bradykinin B2 receptor knockout mice display greater urinary concentrating capacity. Hypertension, 30: 1997.
54. Kakuchi, J., Ichiki, T., Kiyami, S., Hogan, B. L. M., Fogo, A., Inagami, T. and Ichikawa, I.: Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int., 47: 140, 1995.
55. Ray, P. E., Bruggeman, L. A., Horikoshi, S., Aguilera, G. and Klotman, P. E.: Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. Kidney Int., 45: 177, 1994.
56. Friberg, P., Sundelin, B., Bohman, S. O., Bobik, A., Nilsson, H., Wickman, A., Gustafsson, H., Petersen, J. and Adams, M. A.: Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int., 45: 485, 1994.
57. Chen, X., Li, W., Yoshida, H., Tsuchida, S., Nishimura, H., Takemota, F., Okubo, S., Fogo, A., Matsusaka, T. and Ichikawa, I.: Targeting deletion of angiotensin type 1A or 1B receptor gene in the mouse. Amer. J. Physiol., 272: F299, 1997.
58. Matsusaka, T., Nishimura, H., Utsunomiya, H., Kakuchi, J., Niimura, F., Inagami, T., Fogo, A. and Ichikawa, I.: Chimeric mice carrying 'regional' targeted deletion of the angiotensin type 1A receptor gene. Evidence against the role for local angiotensin in the in vivo feedback regulation of renin synthesis in juxtaglomerular cells. J. Clin. Invest., 98: 1867, 1996.
59. Ito, M., Oliverio, M. I., Mannon, P. J., Best, C. F., Maeda, N., Smithies, O. and Coffman, T. M.: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc. Natl. Acad. Sci., 92: 3521, 1995.
60. Tsuchida, S., Matsusaka, T., Chen, X., Okubo, S., Niimura, F., Nishimura, H., Fogo, A., Utsonomiya, H., Inagami, T. and Ichikawa, I.: Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J. Clin. Invest., 101: 755, 1998.
61. Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B. L. and Inagami, T.: Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type-2 receptor. Nature, 377: 748, 1995.
62. Hein, L., Barsh, G. S., Pratt, R. E., Dzau, V. J. and Kobilka, B. K.: Behavioral and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature, 377: 744, 1995.
63. Koseki, C., Herzlinger, D. and al-Awqati, Q.: Apoptosis in metanephric development. J. Cell Biol., 119: 1327, 1992.
64. Miyazaki, Y., Nishimura, H., Harris, R. C., McKenna, J. M., Inagami, T. and Ichikawa, I.: Angiotensin regulates embryonic development of the ureter via type 1 (AT1) and type 2 (AT2) receptors. J. Amer. Soc. Nephrol., 8: 405A, 1997.
65. Yerkes, E., Nishimura, H., Hohenfellner, K., Hunley, T. E., Yoshida, H., Kon, V., Phillips, J. A., III, Brock, J. W., III and Ichikawa, I.: Association between the angiotensin type 2 receptor (AT2) genotype and congenital urinary tract anomalies (CUTA) in two independent cohorts. J. Amer. Soc. Nephrol., 8: 397A, 1997.
66. Matsusaka, T., Hymes, J. and Ichikawa, I.: Angiotensin in progressive renal diseases: theory and practice (editorial). J. Amer. Soc. Nephrol., 7: 2025, 1996.
67. Matsusaka, T. and Ichikawa, I.: Biological functions of angiotensin and its receptors. Ann. Rev. Physiol., 59: 395, 1997.
68. Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F., Motolese, M., Ponticelli, C., Ritz, E., Zuchelli, P. and the Angiotensin-converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group: Effect of the angiotensin-enzyme inhibitor benazepril on progression of chronic renal insufficiency. New Engl. J. Med., 334: 939, 1996.
69. Johnson, R. J., Alpers, C. E., Yoshimura, A., Lombardi, D., Pritzl, P., Floege, J. and Schwartz, S. M.: Renal injury from angiotensin II medicated hypertension. Hypertension, 19: 464, 1992.
70. Nakamura, T., Miller, D., Ruoslahti, E. and Border, W. A.: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int., 41: 1213, 1992.
71. Baricos, W. H., Cortez, S. L., el-Dahr, S. S. and Schnaper, H. W.: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int., 47: 1039, 1995.
72. Vaughan, D. E., Lazos, S. A. and Tong, K.: Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J. Clin. Invest., 95: 995, 1995.
73. Yoshida, H., Kon, V. and Ichikawa, I.: Polymorphisms of the renin-angiotensin system genes in progressive renal diseases (editorial). Kidney Int., 50: 732, 1996.
74. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P. and Soubrier, F.: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest., 86: 1343, 1990.
75. Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J. P., Arveiler, D., Luc, G., Bard, J. M., Bara, L., Ricard, S., Tiret, L., Amouyel, P., Alhenc-Gelas, F. and Soubrier, F.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature, 359: 641, 1992.
76. Schunkert, H., Hense, H. W., Holmer, S. R., Stender, M., Perz, S., Keil, U., Lorell, B. H. and Riegger, G. A.: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. New Engl. J. Med., 330: 1634, 1994.
77. Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., Hunt, S. C., Hopkins, P. N., Williams, R. R., Lalouel, J. M. and Corvol, P.: Molecular basis of human hypertension: role of angiotensinogen. Cell, 71: 169, 1992.
78. Tiret, L., Bonnardeaux, A., Poirier, O., Marquex-Vidal, P., Evans, A., Arveilier, D., Luc, G., Kee, F., Ducimetiere, P., Soubrier, F. and Cambien, F.: Synergistic effects of angiotensin-converting enzyme gene and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet, 344: 910, 1994.
79. Hunley, T. E., Julian, B. A., Phillips, J. A., III, Summar, M. L., Yoshida, H., Horn, R. G., Brown, N. J., Fogo, A., Ichikawa, I. and Kon, V.: Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int., 49: 571, 1996.
80. Yoshida, H., Mitarai, T., Kawamura, T., Kitajima, T., Miyazaki, Y., Nagasawa, R., Kawaguchi, Y., Kubo, H., Ichikawa, I. and Sakai, O.: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J. Clin. Invest., 96: 2162, 1995.
81. Harden, P. N., Geddes, C., Rowe, P. A., McIlroy, J. H., Boulton, H. M., Roger, R. S., Junor, B. J., Briggs, J. D., Connell, J. M. and Jardine, A. G.: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet, 345: 1540, 1995.
82. Marre, M., Jeunemaitre, X., Gallois, Y., Rodier, M., Chatellier, G., Sert, C., Dusselier, L., Kahal, Z., Chaillous, L., Halimi, S., Muller, A., Sackmann, H., Bauduceau, B., Bled, F., Passa, P. and Alhenc-Gelas, F.: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) Study Group. J. Clin. Invest., 99: 1585, 1997.
83. Yoshida, H., Kuriyma, S., Atsumi, Y., Tomonari, H., Mitarai, T., Hamaguchi, A., Kubo, H., Kawaguchi, Y., Kon, V., Matsusaka, T., Ichikawa, I. and Sakai, O.: Accelerated course of progression to chronic renal failure in NIDDM patients with the deletion of polymorphism of the angiotensin converting enzyme gene. Kidney Int., in press.
84. Pei, Y., Scholey, J., Thai, K., Suzuki, M. and Cattran, D.: Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. J. Clin. Invest., 100: 814, 1997.
85. Brock, J. W., III, Adams, M. C., Hunley, T. E., Wada, A., Trusler, L. and Kon, V.: Potential risk factors associated with progressive renal damage in childhood urological diseases: the role of angiotensin-converting enzyme gene polymorphism. J. Urol., 158: 1308, 1997.